Vaginal Microbial Imbalance and Genital Infections: A Review Highlights Challenges for Treatment Research

Background
A literature review of the association between vaginal microbial imbalance and genital infections examined the potential and limitations of treatment research aimed at restoring the microbial community. Published in the International Journal of Women's Health, the paper brought together existing literature on bacterial, fungal, parasitic, and viral infections and their relationships with the vaginal microbiota, immune responses, and antimicrobial resistance. It did not present its own patient or animal experiments or new analytical data.
The vaginal epithelium and its microbial community jointly shape the local defense environment. According to the review, lactic acid produced by bacteria of the genus Lactobacillus helps keep vaginal pH below 4.5. However, protective effects are not identical across bacteria within the same genus.
Antimicrobial treatment remains standard for most vaginal infections. High recurrence rates, biofilms, and antimicrobial resistance were identified as factors that limit long-term treatment effectiveness. The review discusses the need to study the microbial environment in which pathogens establish themselves and persist.
Key findings
The review describes reduced Lactobacillus abundance, increased vaginal pH, and an increase in anaerobic bacteria as key features of bacterial vaginosis. Multispecies biofilms involving Gardnerella vaginalis and other bacteria can form on the vaginal epithelium. The authors summarize prior evidence that biofilms impede drug penetration and contribute to the survival of slow-growing or dormant bacteria. These are discussed as factors that help explain infection persistence and recurrence after treatment.
Vulvovaginal candidiasis was examined as a distinct infection pattern. According to the review, Candida albicans may be present without symptoms, but when local defenses and immune function weaken, it can shift from the yeast form to the hyphal form and attack epithelial tissue. The paper did not directly observe a sequential mechanism in which Candida infection necessarily follows bacterial vaginosis.
The review also covered infections with Trichomonas vaginalis, human papillomavirus (HPV), and human immunodeficiency virus (HIV). Changes in the microbial community were described as associated with susceptibility to infection or viral persistence. These associations should not be interpreted as a single cause shared by all infections or as a unidirectional causal relationship.
Differences among bacterial species were another major topic. Communities dominated by Lactobacillus crispatus are generally associated with favorable vaginal health. By contrast, Lactobacillus iners may be linked to transitional or less stable community states. This means that total Lactobacillus abundance alone is insufficient to assess protective function.
Implications and outlook
The authors reviewed probiotics, microbe-derived substances, and vaginal microbiota transplantation as research approaches to restoring the community. They noted that engraftment and long-term persistence of administered strains are inconsistent, and that strain-specific genomic characteristics and suitability for different patient community types remain insufficiently understood. Further validation is needed before promising results can be regarded as established efficacy and safety in routine care.
Gene editing and technologies using bacteriophages—viruses that target bacteria—were also presented as future research directions. Many of these emerging technologies remain at the preclinical or early translational research stage. The authors emphasized that mechanistic studies, large-scale clinical trials, and long-term safety assessments are needed before clinical application. Whether they can replace existing treatments and which patients they are suitable for remain questions requiring investigation.
Source: Full review.
The maintenance of vaginal microbial homeostasis is essential for women's reproductive health, serving as a primary defense against genital tract infections. Disruption of this ecosystem (dysbiosis) is associated with chronic inflammation, recurrent infections, adverse pregnancy outcomes, and increased susceptibility to sexually transmitted infections. This comprehensive review examines the consequences of this disruption, addressing all categories of vaginal infections, including bacterial, viral, parasitic, and fungal. A specific focus is placed on Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and
This review outlines why research on recurrent vaginal infections should assess both pathogen clearance and restoration of the microbial community. One concrete application is the design of future probiotic clinical trials. Trials could distinguish the characteristics of administered strains and patients' baseline community types, then assess the persistence of engraftment alongside symptoms, recurrence, and safety. This approach would examine whether patients experience lasting benefits, in addition to whether Lactobacillus abundance increases. Biofilm-targeting substances also need testing to determine whether their inhibitory effects in the laboratory translate into actual treatment outcomes. These are potential applications arising from research gaps identified in the review; they do not constitute a recommendation for any particular product or evidence of reduced antimicrobial use or resistance risk.